Diversity
Fighting for Diversity and Equity in Pharma and Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-05Mar 06, 2025
Continuous
The Future is Continuous: Accelerating the Shift in Biomanufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-08Mar 02, 2025
Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11Mar 02, 2025
Orphan Drugs
From Market Failures to Lifesaving Innovations: The Evolution of Orphan Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-06Mar 02, 2025
Cannabinoids
Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-04Mar 02, 2025
Biosimilars
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-01Mar 02, 2025
Microbiome
Harnessing the Human Microbiome: 30 Years of Discovery and Innovation in Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-02Mar 02, 2025
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02Jun 11, 2024